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Abstract
Background: The risks of intracranial haemorrhage (ICH) post intra-arterial therapy (IAT) for stroke are not well
understood. We aimed to study the influence of recanalization status post IAT for anterior circulation stroke and
posterior circulation stroke on ICH development.
Methods: Retrospective analysis of 193 patients in a prospectively collected database of IAT stroke patients was
performed. Successful recanalization was defined as a Thrombolysis in Cerebral Infarction Score of 2b or 3 and
symptomatic ICH (SICH) as parenchymal hematoma type 2 (PH2) with neurological deterioration. The association
between the recanalization status and ICH/SICH was investigated using logistic regression models adjusted for
baseline characteristics selected by univariate analyses.
Results: One hundred and thirty-six patients had successful recanalization post procedure, 41 patients developed
ICH and 10 patients SICH. There was a statistically significant baseline imbalance between the groups with and
without successful recanalization on gender, baseline National Institute of Health Stroke Scale (NIHSS) score, the use of
intravenous tPA and intra-arterial urokinase (p <0.05). Logistic regression analysis adjusted for the above variables and the
time to digital subtraction angiography demonstrated a statistically significant association between successful
recanalization and ICH (odds ratio 0.42; 95 % CI 0.19, 0.95; p = 0.04).
Conclusion: Successful recanalization post endovascular therapy is statistically significantly and negatively associated
with ICH.
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Background
Intracranial haemorrhage (ICH) is a significant compli-
cation of both intravenous tissue plasminogen activator
(IV tPA) and intra-arterial therapy (IAT). Parenchymal
haemorrhage is associated with poor clinical outcomes,
with increased rates of deterioration after 24 h, disabil-
ity and death after 3 months post stroke [1]. The inci-
dence of ICH is similar between IAT and IV tPA,
reaching up to 43 % in some studies [2]. To date, IV
tPA or IV tPA with IAT are the only proven therapy for
acute ischaemic stroke [3]. However, IV tPA by itself is
associated with low rates of recanalization (38 % for
internal carotid artery, 44 % for M1, 44 % for single M2
occlusion), compared to 65 %, 81 % and 70 %, respect-
ively for IAT [4]. Given the uncertain efficacy of IAT,
there is emerging interest in the identification of risk
factors for ICH post intervention for safety purposes.
Animal studies showed increased incidence of haemor-
rhagic transformation post IV tPA with increasing duration
of arterial occlusion [5–7]. In human studies, delayed
recanalization was also associated with haemorrhagic trans-
formation [8, 9]. Disruption to the blood brain barrier was
the presumed culprit mechanism for the development of
haemorrhagic transformation. Blood brain barrier failure
was thought to progress in steps, from reactive hyperaemia
to hypoperfusion, resulting in increased paracellular perme-
ability. The estimated time to blood brain barrier disrup-
tion was posited at approximately 3.8 h [10].
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The associative factors of post-tPA related ICH have
been well studied [11] and included high National
Institutes of Health Stroke Scale (NIHSS) score, brain
oedema, hyperglycaemia, mass effect and early ischae-
mic changes on neuroimaging [12]. On the other hand,
there is less data on the predictors of intracranial
haemorrhage post IAT.
The aim of our study was to investigate the influence
of recanalization success on the incidence of ICH in pa-
tients treated with IA therapy for acute ischaemic stroke.
We hypothesised that successful recanalization in stroke
patients is associated with decreased risk of ICH.
Methods
This research was approved by the Human Research
Ethics Committee of Royal Melbourne Hospital, in com-
pliance with the Helskinki Declaration, and has waived
consent for this research.
A retrospective analysis of a prospectively collected data-
base of all patients from a single centre, who underwent
intra-arterial therapy between October 2007 and November
2013, was performed. The selection for the patients for
intra-arterial therapy included patients with CT or cerebral
digital subtraction angiogram (DSA) evidence of: (1) M1,
M2 or internal carotid artery occlusion within 4.5 h of
stroke symptoms; or (2) occlusion in the basilar or vertebral
arteries within 24 h of symptoms. There were no age
restrictions. Patients with a pre-existing modified Rankin
Scale (mRS) >3, plain CT or CT perfusion evidence of
infarct core greater than one third of the MCA territory
were excluded.
A range of IA treatments were available during this
period including IA tPA, IA urokinase and mechanical
thrombectomy (MERCI, Penumbra or Solitaire).
Data collected include patient demographics, vascular
risk factors, baseline NIHSS, time from onset of symptoms
to digital subtraction angiography (DSA), use of IV tPA as
well as post-procedural imaging documenting recanaliza-
tion as well as the presence and type of ICH on follow up
CT brain. Post-treatment recanalization was classified
using the Interventional Management of Stroke (IMS) II
Study Thrombolysis in Cerebral Infarction (TICI) grading
[13]. In keeping with previous studies, TICI grade 2a and
below were deemed as unsuccessful recanalization and
TICI 2b and 3 as successful recanalization [14]. ICH was
sub-typed according to the European Cooperative Acute
Stroke Study (ECASS) II classification [15]. SICH was
defined as parenchymal hematoma type 2 (PH2) with
neurological deterioration (greater than or equal to 4 point
deterioration on NIHSS from baseline), as this definition
has a good prediction for both mortality and outcome [16].
Cerebral DSA was performed on a biplane neurointer-
ventional angiography unit (Axiom Artis dBC, Siemens
Healthcare, Germany). CTs were performed on a 64
MDCT scanner (Somaton Sensation 64, Siemens Health-
care, Germany).
Judgement of TICI and symptomatic haemorrhage
were determined by the consensus of three experienced
neurointerventionalists.
Statistical analysis
Statistical analysis was performed using Stata 13IC
(StatCorp LP, Texas, USA). Univariate analysis was per-
formed using Fischer’s exact test for categorical variables
and two-sample Wilcoxon rank-sum test for ordinal and
continuous variables to identify statistically significant im-
balances on baseline variables between the groups with
and without successful recanalization. Binary logistic re-
gression adjusting for these baseline variables as well as
for the time to DSA was then performed using recanaliza-
tion status as independent variable and ICH/SICH as the
dependent variable. Standard diagnostics of collinearity
and assessments of model fit were performed.
Results
A total of 193 patients underwent IAT in this time period.
Median age for the cohort was 67 (IQR: 56, 75) years. Of
these, 70 (36.3 %) were women, 33 (17.1 %) had diabetes,
95 (49.2 %) hypercholesterolemia, 61 (31.6 %) AF, 28
(14.5 %) ischaemic heart disease (IHD) and 22 (11.4 %)
previous stroke or transient ischaemic attack (TIA). Me-
dian baseline NIHSS was 17 with 11 and 22 as the inter-
quartile ranges. Mean time from onset of symptoms to
DSA was 347.9 ± 235.6 min. The exact time of onset of
symptoms was unable to be determined in 4 patients. 132
patients had anterior circulation occlusions, while 61
patients had posterior circulation occlusions.
136 patients (70.5 %) had successful recanalization
post treatment (TICI grades 2b and 3).
ICH occurred in 41 patients (21.2 %) and SICH in 10
patients (5.2 %). No ICH was due to vessel perforation
or rupture.
Baseline characteristics, as well as treatment method
and time to treatment between the groups with success-
ful and unsuccessful recanalization are summarised in
Table 1. The baseline characteristics statistically signifi-
cantly different (p-value <0.05) between the two groups
are gender, baseline NIHSS, the use of IV tPA and IA
urokinase. Median time to DSA was 287 (IQR: 238, 406)
for the unsuccessful recanalization group compared to
274 (IQR: 200, 363) for the successful recanalization
group (Wilcoxon-Mann–Whitney p = 0.14).
Breakdown of recanalization, ICH and SICH numbers
are shown in Table 2.
There was a statistically significant inverse relationship
between the recanalization status and ICH adjusted for
gender, baseline NIHSS, the use of IV tPA, IA urokinase
and time to DSA (adjusted OR = 0.42, 95 % CI: 0.19,
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0.95, p = 0.038). Similar analysis did not identify a sta-
tistically significant association between the recanali-
zation status and SICH (adjusted OR = 0.24, 95 % CI:
0.05, 1.1; p = 0.07). Multivariable logistic regression
analyses for ICH and SICH are shown in Tables 3
and 4, respectively.
Discussion
Unsuccessful recanalization at the end of IAT and higher
baseline NIHSS are shown to be independent predictors
of any ICH, after controlling for gender, use of IV tPA, IA
urokinase and time to DSA. None of the variables identi-
fied were found to be a significant predictor of SICH.
Findings are comparable to the previous studies with
IV tPA showing an association with persisting arterial
occlusion and haemorrhagic transformation [8, 9].
For IAT, one study has shown the presence of diabetes
mellitus and higher baseline NIHSS to be independent
predictors of any ICH post IAT and the non-use of IA tPA,
presence of AF and higher baseline NIHSS to the inde-
pendent predictors of parenchymal haematoma [17]. Suc-
cessful recanalization was not shown to be a predictor for
ICH in that study. In that study, the criteria for defining re-
canalization was the Thrombolysis in Myocardial Infarction
(TIMI) grade. The newer TICI grading is more specific for
assessment of cerebral perfusion and the now widely
accepted criteria for grading of successful perfusion on
TICI (grades 2b and 3) is stricter than that for TIMI
(grades 2 or 3). Difference in the definition for successful
recanalization is the most likely reason for this discrepancy.
Our study shows that patients who had successful re-
canalization post IAT within 4 h for anterior circulation
stroke or 12 h for posterior circulation is at a decreased
Table 1 Baseline characteristics by recanalization status
Unsuccessful recanalization (n = 57) Successful recanalization (n = 136) p-value
Age 70 (57, 76)a 66 (55, 76)a 0.46
Gender 0.008
Male 28 (49.1 %) 95 (69.9 %)
Female 29 (50.9 %) 70 (36.3 %)
Type 2 Diabetes Mellitus 10 (17.5 %) 23 (16.9 %) >0.99
Hypertension 28 (49.1 %) 67 (49.3 %) >0.99
Hypercholesterolemia 17 (29.8 %) 40 (29.4 %) >0.99
Atrial fibrillation 16 (28.1 %) 45 (33.1 %) 0.61
Ischaemic heart disease 7 (12.3 %) 21 (15.4 %) 0.66
Previous stroke or TIA 5 (8.8 %) 17 (12.5 %) 0.62
Baseline NIHSS 20 (14, 26)a 15.5 (10, 20)a 0.001
Time to DSA (minutes)b 287 (238, 406)a 274 (200, 363)a 0.14
IV tPA 8 (14.0 %) 60 (44.1 %) 0.00
IA urokinase 32 (56.1 %) 49 (36.0 %) 0.01
IA tPA 8 (14.0 %) 12 (8.8 %) 0.31
Anterior circulation occlusion 39 (68.4 %) 93 (68.4 %) >0.99
Baseline and treatment variables, with univariate analysis. Fischer’s exact test was performed for categorical variables and two-sample Wilcoxon rank-sum test for
ordinal and continuous variables. aMedian (1st quartile, 3rd quartile). bData from 4 patients unable to be calculated










Unsuccessful recanalization 57 21 6
0 25 6 2
1 10 6 2
2a 22 9 2
Successful recanalization 136 20 4
2b 39 6 2
3 97 14 2
TICI grades 0-2a inclusive are considered unsuccessful recanalization, and
grades 2b and 3 as successful recanalization
Table 3 Binary multivariable logistic regression analysis for ICH
Factor Odds ratio 95 % CI p-value
Successful recanalization 0.42 0.19 – 0.95 0.04
Gender 0.76 0.35 – 1.64 0.48
IV tPA 0.70 0.29 – 1.72 0.44
IA urokinase 1.52 0.71 – 3.23 0.28
Baseline NIHSS (per point) 1.04 1.001 – 1.082 0.047
Time to DSA (per minute) 1.00 0.998 – 1.002 0.98
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risk of ICH. This is most likely because revascularisation
of the brain tissue has occurred before significant failure
to the blood brain barrier has occurred.
Although on the multivariable analysis, successful re-
canalization was not found to be significantly associated
with SICH (p-value 0.07), this may be attributed to the
small numbers of SICH (n = 10) and decreased statistical
power to detect this effect.
It is unknown whether the association between unsuc-
cessful cerebral perfusion and the development of ICH
is cause and effect. There may be other unidentified fac-
tor or factors that make it more difficult to achieve suc-
cessful recanalization, which ultimately may be the cause
of ICH. On the other hand, if there is direct cause and
effect, increased persistence in achieving TICI grades 2b
and 3 could be pursued to decrease the risk of ICH. In
the absence of definitive data, the decision for more ag-
gressive recanalization remains a clinical one.
Baseline NIHSS is shown to be weakly associated with
ICH formation but not SICH.
Limitations to this study include the fact that data is
only collected from a single centre. The numbers of pa-
tients with SICH were also too small to draw confident
conclusions regarding the association with SICH and re-
canalization. Unsuccessful recanalization was determined
at the end of the endovascular procedure, with possible
reopening of the artery after this point as a confounder.
Conclusion
We showed that in our study, failure of recanalization
at the end of endovascular stroke therapy is associated
with ICH.
Competing interests
The authors declare that they have no conflict of interest.
Authors’ contributions
DW carried out data analysis and drafting of manuscript. LC carried out data
analysis and manuscript writing. RD, PM and BY were involved in project
development, data collection and manuscript writing. All authors read and






1Department of Radiology, Royal Melbourne Hospital, University of
Melbourne, Parkville, VIC, Australia. 2Florey Institute of Neuroscience and
Mental Health, Melbourne, Australia. 3RMIT University, Melbourne, Australia.
4Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne,
300 Grattan St, Parkville, Victoria 3050, Australia.
Received: 24 March 2015 Accepted: 25 September 2015
References
1. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al.
Hemorrhagic transformation of ischemic brain tissue: Asymptomatic or
symptomatic? Stroke. 2001;32:1330–5.
2. IMS Study Investigators. Hemorrhage in the interventional management of
stroke study. Stroke. 2006;37:847–51.
3. Wardlaw JM, Koumellis P, Liu M. Thrombolysis (different doses, routes of
administration and agents) for acute ischaemic stroke. Cochrane Database
Syst Rev. 2013;5:CD000514.
4. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al.
Endovascular therapy after intravenous t-pa versus t-pa alone for stroke.
N Engl J Med. 2013;368:893–903.
5. Copin JC, Gasche Y. Effect of the duration of middle cerebral artery
occlusion on the risk of hemorrhagic transformation after tissue
plasminogen activator injection in rats. Brain Res. 2008;1243:161–6.
6. Fagan SC, Nagaraja TN, Fenstermacher JD, Zheng J, Johnson M, Knight RA.
Hemorrhagic transformation is related to the duration of occlusion and
treatment with tissue plasminogen activator in a nonembolic stroke model.
Neurol Res. 2003;25:377–82.
7. Fagan SC, Garcia JH. Hemorrhagic transformation in focal cerebral ischemia:
Influence of time to artery reopening and tissue plasminogen activator.
Pharmacotherapy. 1999;19:139–42.
8. Molina CA, Montaner J, Abilleira S, Ibarra B, Romero F, Arenillas JF, et al.
Timing of spontaneous recanalization and risk of hemorrhagic
transformation in acute cardioembolic stroke. Stroke. 2001;32:1079–84.
9. Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Siddiqui M, Alvarez-Sabin J,
et al. Symptomatic intracerebral hemorrhage and recanalization after iv rt-pa:
A multicenter study. Neurology. 2008;71:1304–12.
10. Khatri R, McKinney AM, Swenson B, Janardhan V. Blood–brain barrier,
reperfusion injury, and hemorrhagic transformation in acute ischemic stroke.
Neurology. 2012;79:S52–57.
11. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after
intravenous t-pa therapy for ischemic stroke. Stroke. 1997;28:2109–2118
12. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et
al. Markers of increased risk of intracerebral hemorrhage after intravenous
recombinant tissue plasminogen activator therapy for acute ischemic stroke
in clinical practice: The multicenter rt-pa stroke survey. Circulation.
2002;105:1679–85.
13. Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, et al.
Revascularization results in the interventional management of stroke ii trial.
AJNR Am J Neuroradiol. 2008;29:582–7.
14. Cheang MY, Manning N, Churilov L, Mitchell P, Dowling R, Yan B.
Recanalisation success is associated with good clinical outcome despite
advanced age and stroke severity in patients treated with the Solitaire
stentriever. J Clin Neurosci. 2014;21:401–5.
15. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al.
Randomised double-blind placebo-controlled trial of thrombolytic therapy
with intravenous alteplase in acute ischaemic stroke (ecass ii). Second
european-australasian acute stroke study investigators. Lancet. 1998;352:1245–51.
16. Gumbinger C, Gruschka P, Bottinger M, Heerlein K, Barrows R, Hacke W,
et al. Improved prediction of poor outcome after thrombolysis using
conservative definitions of symptomatic hemorrhage. Stroke. 2012;43:240–2.
17. Nogueira RG, Gupta R, Jovin TG, Levy EI, Liebeskind DS, Zaidat OO, et al.
Predictors and clinical relevance of hemorrhagic transformation after
endovascular therapy for anterior circulation large vessel occlusion strokes:
A multicenter retrospective analysis of 1122 patients. J Neurointerv Surg.
2014;7(1):16–21.
Table 4 Binary multivariable logistic regression analysis for SICH
Factor Odds ratio 95 % CI p-value
Successful recanalization 0.24 0.05 – 1.10 0.066
Gender 1.72 0.39 – 7.59 0.47
IV tPA 0.83 0.14 – 4.84 0.84
IA urokinase 0.52 0.12 – 2.15 0.36
Baseline NIHSS (per point) 1.02 0.95 – 1.08 0.62
Time to DSA (per minute) 1.00 0.999 – 1.004 0.13
Wang et al. BMC Neurology  (2015) 15:185 Page 4 of 4
